Masashi Suganuma

Title: Masashi Suganuma: Innovator in Cell Cycle Research

Introduction

Masashi Suganuma is a prominent inventor based in Toyota, Japan. He has made significant contributions to the field of cell cycle research, particularly in the context of cancer treatment. With a total of 2 patents, Suganuma's work focuses on innovative methods to enhance the effectiveness of cancer therapies.

Latest Patents

Suganuma's latest patents include compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents. The invention provides compositions and methods for inhibiting Chk1 and/or Chk2 kinases. These methods are particularly aimed at treating disorders of cell growth, such as cancer. The invention also offers methods for selectively sensitizing G1 checkpoint impaired cancer cells to DNA damaging agents and treatments. Additionally, it includes methods for screening compounds that can interact with enzymes involved in the G2 cell cycle arrest checkpoint.

Career Highlights

Masashi Suganuma is currently associated with Canbas Co., Ltd., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on cancer therapies and cell growth disorders.

Collaborations

Suganuma collaborates with Takumi Kawabe, contributing to the development of innovative solutions in their field.

Conclusion

Masashi Suganuma's contributions to cell cycle research and cancer treatment exemplify the importance of innovation in medical science. His patents reflect a commitment to improving therapeutic strategies for cancer patients.